Elecsys C-Peptide Calcheck
Single (Specified) Analyte Controls (Assayed And Unassayed). 510(k) K040157, from Roche Diagnostics Corp. (Indianapolis, IN). Product code JJX, class 1.
As of Nov 20, 2026, K040157 is an FDA 510(k) held by Roche Diagnostics Corp., substantially equivalent on Feb 25, 2004 after 33 days, with no recalls tied to it in FDA's recall database.
- Review time: 33 days
- Recalls: 0
- Cited as a predicate by: 6 devices
The Elecsys® C-Peptide CalCheck is intended for use in the verification of the calibration established by the Elecsys® C-Peptide reagent on the Elecsys® immunoassay systems.
- Elecys Shbg CalcheckK031698 · Roche Diagnostics Corp. · Aug 20, 2003
- Elecsys C-Peptide Calcheck 5K100810 · Roche Diagnostics · Apr 26, 2010
- Elecys Anti-Ccp CalcheckK091601 · Roche Diagnostics Corp. · Sep 25, 2009
- Elecsys Rubella Igg CalcheckK090311 · Roche Diagnostics · May 5, 2009
- Elecsys Toxo Igg CalcheckK083655 · Roche Diagnostics · Feb 12, 2009
- Elecsys Anti-Tshr CalcheckK080643 · Roche Diagnostics · Aug 22, 2008
- Elecsys Ca 19-9 CalcheckK051185 · Roche Diagnostics Corp. · Jul 6, 2005
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jan 23, 2004
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1660
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files